Smokin' hot: adolescent smoking and the risk of psychosis Mustonen A, Ahokas T, Nordstr€ om T, Murray GK, M€ aki P, J€ a€ askel€ ainen E, Heiskala A, Mcgrath JJ, Scott JG, Miettunen J, Niemel€ a S. Smokin' hot: adolescent tobacco smoking and the risk of psychosis Objective: Daily smoking has been associated with a greater risk of psychosis. However, we are still lacking studies to adjust for baseline psychotic experiences and other substance use. We examined associations between daily smoking and psychosis risk in a 15-year follow-up while accounting for these covariates in a prospective sample (N = 6081) from the Northern Finland Birth Cohort 1986. Methods: Self-report questionnaires on psychotic experiences (PRODscreen), tobacco smoking and other substance use were completed when the cohort members were 15-16 years old. Tobacco smoking was categorized into three groups (non-smokers, 1-9 cigarettes and ≥10 cigarettes/day). Psychosis diagnoses were obtained from national registers until the age of 30 years. Results: Subjects in heaviest smoking category were at increased risk of subsequent psychosis (unadjusted HR = 3.15; 95% CI 1.94-5.13). When adjusted for baseline psychotic experiences the association persisted (HR = 2.87; 1.76-4.68) and remained significant even after adjustments for multiple known risk factors such as cannabis use, frequent alcohol use, other illicit substance use, parental substance abuse, and psychosis. Furthermore, number of smoked cigarettes increased psychosis risk in a dose-response manner (adjusted OR = 1.05; 1.01-1.08). Conclusion: Heavy tobacco smoking in adolescence was associated with a greater risk for psychosis even after adjustment for confounders. 
Introduction
The higher rates of smoking tobacco by patients with psychotic disorders (1, 2) have generally been assumed to be due to self-medication strategies and some studies have suggested a possible bidirectional association (3) (4) (5) . However, two meta-analyses have reported strong associations between tobacco smoking and an increased risk of subsequent psychosis diagnosis (6, 7) . A dose-response effect has also been reported in two large Swedish cohorts (8) , in an Israeli conscript cohort (9) and in a Danish cohort of women (10) . Furthermore, the association has persisted in prospective samples after adjustment for risk factors such as socioeconomic status and drug use (8) (9) (10) . With the exception of one study reporting cigarette smoking in young adults reduced later onset of schizophrenia (11) , prospective samples (8) (9) (10) have provided strong evidence of the association between smoking and psychosis. Although there are longitudinal studies that have examined the temporal order of this association (2, 8, 11) , there are none that have accounted for baseline psychotic experiences which has left the direction of the association questionable. Furthermore, there are no longitudinal samples that have examined this hypothesis in an adolescent population and it is plausible that adolescent substance use could potentially alter the trajectories of brain maturation and mental health.
Aims of the study
Within our population-based birth-cohort, our objective was to study whether daily smoking at age 15-16 years is associated with the risk of subsequent ICD-10 psychosis by the age of 30 years using nationwide registers. Information on psychotic experiences of psychosis was ascertained using self-report when the study population was 15-16 years old. We hypothesized that (i) daily smoking in adolescence is an independent risk factor for later psychosis, (ii) increases the risk in a dose-response manner, and (iii) early initiation of daily smoking results in greater risk of psychosis compared with late initiation of daily smoking after adjusting for multiple confounders such psychotic experiences and substance use.
Methods

Participants
The Northern Finland Birth Cohort (NFBC) 1986 is an ongoing general population-based study including 99% of all births between July 1, 1985 and June 30, 1986 from the two northernmost provinces in Finland. The current sample included all the live-born children (n = 9432) (12) . In all, 7344 participated in the follow-up postal questionnaire and 6798 in the follow-up field study in [2001] [2002] , when the participants were aged 15-16 years. Consenting participants who answered the questions on smoking habits and psychotic experiences (PROD-screen) were included in this study. Adolescents who had received a psychosis diagnosis prior to assessment at 15-16 years (n = 10), were excluded from the study. The final sample included 6081 individuals (47.7% boys). For data flow, please see Fig. 1 . Information on psychosis-related diagnoses (n = 110) was collected from the national registries until the end of 2015, that is, by the age of average 30 years. The study was approved by the ethics committee of the Northern Ostrobothnia Hospital District in Finland (May 17, 2006) .
Data collection
Data collection commenced prospectively before birth (12) . A multidisciplinary follow-up study was conducted when the adolescents were 15-16 years (13) . Data on substance abuse was collected in 2001-2002, in two different surveys when the adolescents were 15-16 years old. First, they received a postal questionnaire, which included questions on smoking habits. Thereafter, the participants were invited to a field study where they completed self-report questionnaires including questions on psychotic experiences (PROD-screen) (14) , alcohol use, illicit substance use, and additional questions on smoking habits.
Measures
Daily tobacco smoking in adolescence
Subjects were considered smokers if they were smoking tobacco daily. Information on regular smoking was collected from postal questionnaires and during the field study (15) . In the postal questionnaire adolescents were asked if they currently smoked cigarettes daily (at least 1 cigarette/day, no/yes), and how many filtered or unfiltered cigarettes they smoked per day (n). The information on number of smoked cigarettes for daily smokers was then divided into groups and we categorized this into three levels (no smoking (reference), 1-9 cigarettes/day and ≥10 cigarettes/day). Rationale for using this categorization was the consistent use of it in the previous prospective samples (8-10).
Subjects who reported any smoking, but did not answer (yes) being daily smokers were considered as non-smokers. In the field study, the subjects were handed a self-report questionnaire where they were asked when they began to smoke daily (11 years or earlier, 12, 13, 14, 15, and 16 years of age). We categorized this variable into two groups based on the median: early initiation of daily smoking (13 years or under) and later initiation of daily smoking (14 years or older). (16) . Age at the time when psychosis was first detected was estimated as the onset age of psychosis. Cumulative incidences of psychoses were calculated.
Psychotic experiences in adolescence
The PROD-screen is a validated questionnaire screening for prodromal symptoms of psychosis (14) . The scale has 12 specific items: These rates, for example, feelings that something strange or inexplicable is taking place in oneself or in the environment, feelings that one is being followed or influenced in some special way, experience of thoughts running wild or difficulty in controlling the speed of thoughts, among other symptoms. Dichotomous responses (no/yes) to these symptoms were sought for the previous 6 months when the cohort members were 15-16 years old (17) . Reporting three or more items were the cut-off for psychotic experiences in this sample which has been used for research (17) (18) (19) and clinical purposes in Finland. Subjects were included in the sample if they had answered at 
Other variables
Alcohol, cannabis, and other substance use. Information on substance use was collected in the selfreport questionnaire that the participants received during clinical examinations in adolescence. Frequent drunkenness was questioned as subjective measure 'Have you been drunk during the past year (0, 1-2, 3-5, 6-9, 10-19, 20-39 or 40 times or more)'. In analyses, this variable was categorized as 'Have you been drunk during the past year 10 times or more (no/yes)'. Cannabis use was assessed by the question 'Have you ever used marihuana or hashish (no/yes)'. Dichotomous responses (no/yes) were also collected on any use of other substances: prescription drug use, ecstasy use, heroin use, cocaine use, amphetamine use, and use of LSD. Because of the low number of users in each group, these were combined as 'Other substance use (no/ yes)' (15) .
Family structure at birth and in adolescence. Information on family structure was gathered from self-reports that were collected from parents at birth and when the cohort member was aged [15] [16] . Subjects that were living with their primary family from birth to adolescence (i.e., living with subject all the time) were classified as (1) 'intact families' and all the others as (2) 'non-intact families'.
Socio-economic status of the family in adolescence. The socio-economic status of the family was estimated by the highest education level achieved by either parent when the child was aged 15-16. This variable was categorized as professionals (professionals, entrepreneurs, and other whitecollar workers) and non-professionals (17) .
Place of residence. Data were collected based on the population density of the residential area at age 15-16 years to account for possible confounding due place of residence. The variable was dichotomized in the analyses (urban vs. nonurban) (20) . 
Statistical methods
Logistic regression with odds ratios (OR; 95% confidence interval, CI) was used to study the crude associations between a) potential covariates and daily smoking (dichotomized), and b) covariates and psychosis diagnosis. Covariates were selected from a comprehensive dataset, based on previous literature (see Table S1 ). Covariates were selected using two-step method: first based on earlier literature, and second on the statistical analyses of this study sample. The literature-based covariates included family characteristics, smoking, alcohol use, and other drug use including cannabis, and parental psychosis and parental substance abuse diagnoses. Thereafter we conducted logistic regression analyses to seek whether the selected covariates were associated with psychosis risk. Logistic regression was used for covariate selection as no time-dependent data were available on tobacco smoking.
In the multivariable models (both crude and adjusted), we used Cox regression analysis (Hazard Ratio, HR; with 95% CI) to assess the effect of adolescent daily smoking (non-smokers, 1-9 cigarettes/day, ≥10 cigarettes/day) on the risk of psychosis. A subanalysis was also conducted, where we examined subjects reporting less than cut-off (<3) in PROD-screen in a model that was similar to the one above. Subjects with missing data were not included in the multivariable analyses if they had not answered the question that was used in the model. In addition, we used Cox regression analyses to study whether the age at initiation of daily smoking (early; before or at 13 years of age vs. late; after 14 years of age) contributed to psychosis risk among daily smokers. Times at emigration and death were used as censoring points in analyses (data until December 2013). We also examined for a dose-response between cigarette smoking and psychosis risk with a trend test, using the number of smoked cigarettes as a continuous variable in the logistic regression analysis. Linear regression and multicollinearity diagnostics were used to detect a correlation between multiple variables.
The statistical analyses for logistic and Cox regression analyses were performed using SPSS 23.0 and the inverse probability of treatment weighting analyses were carried out using R 3.3.2 with packages mice (2.25), survival (2.40-1), and boot (1.3-18) .
The stability of primary Cox regression analysis results was assessed using the inverse probability of treatment weighting (IPTW) based on propensity score with Cox regression. The propensity score is the subject's conditional probability to treatment assignment, in this case to daily smoking, given the observed baseline covariates. It is used in observational studies to reduce selection bias by balancing the baseline characteristics between the treatment and control groups. IPTW based on the propensity score is then used to create a synthetic sample by weighting individual observations. The full description of the method and the demographics are presented in an online supplement.
Results
Study characteristics
The demographics of the study and their relationship with daily tobacco smoking and occurrence of psychosis during the follow-up are presented in Table 1 . In all, there were 745 daily smokers in the sample population. Adolescents with cannabis use, other illicit substance use, and frequent alcohol use were more likely to be smoking daily than those without substance use (P < 0.05 in all, see Table 1 ). Subjects with history of parental substance abuse and parental psychosis were also more likely to be daily smokers compared to those without these parental histories. All of these factors were also associated with a higher incidence of psychosis during the follow-up (see Table 1 ). No significant multicollinearity was present. In total, 1883 adolescents (31% of the sample) endorsed 3 or more items in PROD-screen. Odds Ratio (95% Confidence Interval). Statistically significant (P < 0.10) differences are in bold.
Daily smoking as risk factor for psychosis
Altogether 6081 subjects answered questions concerning the number of cigarettes smoked per day, of these 745 (12.3%) were daily smokers. 110 participants were diagnosed with incident psychosis in this sample population. Compared with non-smokers, those who smoked heavily (>10 cigarettes/ day) were at increased risk of subsequent psychosis (unadjusted HR = 3.15; 95% CI 1.94-5.13), however, there was no association between light smoking (1-9 cigarettes/day) and later psychosis. After adjusting for baseline psychotic experiences the association persisted (highest; HR = 2.87; 1.76-4.68). Further adjustment for cannabis use, frequent alcohol use, other illicit substance use, parental substance abuse, and psychosis (see Table 2 ) attenuated the association, but the association remained significant. Consistent with the data from our primary Cox regressions, the IPTW -analyses further indicate that smoking daily 10 or more cigarettes was a risk factor for psychosis compared with non-smokers (adjusted HR = 3.44, 95% CI 1.61-7.32, see online supplement). Similarly, in the subanalysis of subjects reporting less than three items (cut-off) in PROD-screen, daily smokers with 10 or more cigarettes/day were at increased risk of psychosis (fully adjusted HR = 3.26; 95% CI 1.52-7.01). A dose-response was seen with the trend test (fully adjusted OR = 1.05; 95% CI: 1.01-1.08).
Age at initiation of daily smoking and risk of psychosis
We performed additional analyses to study whether early initiation of daily smoking was associated with a greater risk for subsequent psychosis compared with the late initiation group. 
Attrition
Attrition analysis from our current sample (NFBC 1986) has been presented previously (17) . In this sample, males were less likely to participate in the follow-up study than females (64% v. 71%; v 2 test, P < 0.001), as were participants living in urban areas (66% vs. 71%, P < 0.001). Non-participation in the follow-up study was associated with greater risk for psychosis (HR = 1.52, 95% CI: 1.13-2.04).
Discussion
Consistent with the results of the previous metaanalyses (6, 7) and the prospective cohort studies (8-10), heavy tobacco smoking was an independent risk factor for psychosis even after adjustment for range of confounders. Inclusion of baseline psychotic experiences had only a minor effect on the association suggesting the onset of tobacco smoking preceded symptoms of psychosis. Early initiation of daily smoking was also associated with greater risk of psychosis compared with later initiation.
We found a dose-response effect suggesting an increased magnitude of tobacco smoking in adolescence was associated with greater risk of psychosis. The dose-response effect has been also reported in previous studies and the effect sizes are similar to this sample. A Swedish general population-based study found that heavy smoking was more strongly associated with schizophrenia than light smoking both in males and females even after adjusting for socioeconomic status and drug use (8) . Also, an Israeli military sample study reported that adolescents who smoked 1-9 cigarettes/day were 1.38 times (95% CI: 0.48-4.00) likely to be hospitalized later for schizophrenia and adolescents who smoked 10/cigarettes day or more were 2.28 times (95% CI: 1.19-4.34) as likely (9) . Furthermore, a Danish study reported a linear association between number of smoked cigarettes and later hospitalization for schizophrenia spectrum disorders (10) . Interestingly, light smoking seemed to have a potential protective effect for psychosis. We speculated that adolescents with sporadic smoking could be more likely to smoke because of peer-pressure and social acceptability among adolescents, and therefore be more likely to be socially active and better coping that would likely confer to a lower psychosis risk. Heavy smoking in adolescence was a significant risk factor for psychosis even after adjusting for baseline psychotic experiences and the adjustment had only minor effect on outcome (here 8.6% decrease in HR). Based on our results it is unlikely that the association would arise from reverse causation. Therefore, the hypothesis that smoking could manifest as a part of a prodromal syndrome (2) is not supported in our study. There is other additional evidence against this hypothesis. Kendler et al. examined the smoking-schizophrenia association using buffer periods and found no declining with longer buffer periods either in male or female sample (8) .
Early initiation of daily smoking was also a slightly greater risk factor for psychosis compared with late initiation of daily smoking even after adjusting for many potential confounders. This result is consistent with a previous study (21) , which showed that earlier initiation of ever-smoking was associated with psychosis outcomes. It can be speculated that earlier onset of smoking could result in a greater cumulative dose of nicotine or other harmful byproducts from tobacco over time. It is plausible that excess nicotine intake during vulnerable periods such as early adolescence could influence the balance of dopaminergic and cholinergic neurotransmitters in the brain (22, 23) and disrupt brain maturation (24) and thus contribute to the risk of mental health outcomes. Furthermore, timing of the 'hits' during neurodevelopment may lead to different outcomes whereby earlier hits may cause more widespread abnormalities compared with later exposure (25) .
Adjustment for co-substance use has been lacking in previous psychosis studies (7, 26) . In our study, heavy smoking exposure in adolescence remained a significant risk factor after adjustment for cannabis use, frequent alcohol use and other illicit substance use. The association attenuated significantly indicating that frequent alcohol use, cannabis use, and other illicit substance use are confounders, but some of the decrease in HR is likely due high correlation between daily smoking and other target substances as 38.1% of frequent alcohol users, 49.1% of those who had used cannabis and 63.3% of those who had used other illicit substances were also daily smokers. A recent nationwide Danish study reported associations between different substance abuse diagnoses and risk of schizophrenia (cannabis, alcohol, amphetamine, hallucinogens etc.) (26) although only other illicit substance use than cannabis associated with psychosis in our adjusted analyses. However, we were restricted by relatively low number of other illicit substance users and therefore might be underpowered for these analyses. Our study population might not be not entirely comparable to other samples as we focused on self-reported substance use in adolescence, and included also nonschizophrenic psychoses.
There has been discussion as to whether the smoking-psychosis association arises from genetic or familial factors such as family history of psychosis. Gage et al. studied the association of initiation of smoking and schizophrenia using Mendelian randomization and found out that schizophrenia risk was not causally associated with initiation of smoking (27) . However, bidirectional association between smoking and schizophrenia has been proposed due to findings of common variants between nicotine dependence and schizophrenia (3) (4) (5) , but the shared variants are likely to explain only a fraction of the association. A recent Swedish study found in a co-relative analysis that heavy smokers had an increased risk of non-affective psychosis compared with their non-smoking twin and only a modest decline in HR was reported when comparing full siblings to more distant relatives or the general population (10) .Therefore, it is unlikely that the association could be explained by familial/genetic factors entirely. Here parental psychosis was weakly associated with psychosis in the logistic regressions but did not remain statistically significant in adjusted analyses. Parental substance abuse has been also linked to child mental health outcomes and substance use (28) and to further study this we included it as a potential confounder. However, parental substance abuse did not reach statistical significance for psychosis (see Table 2 ). Confounding due to the parental factors was not present either as adjusting for these parental factors made little difference to the strength of the association (HR decline from 2.87 to 2.73, 4.9%). Although parental factors might influence offspring psychosis and smoking behaviour, it is unlikely these explain the association between adolescent smoking and psychosis.
Strengths and limitations
The strengths of this study include the study sample, the NFBC 1986 is one of the largest birth-cohort studies with high genetic and ethnic homogeneity; the considerable number of daily smokers in the study allowing robust examination of the associations and the dose-response relationship and the use several nationwide registers combined with a very small proportion of cohort members deceased or emigrated during the follow-up. Therefore, the coverage of clinically significant psychosis diagnoses within this population during the 15-year follow-up can be considered high (16) . Indeed, the incidence rate in this sample was 121 per 100 000 per year, which is significantly higher than in most of the previous samples (29) (30) (31) . Furthermore, our extensive dataset provided information on a range of possible confounders. However, there are also limitations: Like all large longitudinal studies, there was attrition and the information on substance abuse was collected using selfreports, which may give rise to a bias of underreporting and therefore possible underestimation of the true association. As males and subject from urban areas were less likely to participate in the follow-up study in 2001-2002, some selection might be present. The data concerning psychotic experiences was gathered when the study population was around 15-16 years old, so it is possible that some subjects might have experienced these symptoms before the onset of substance use reflective of reverse causality. Although the PROD-screen has been validated in previous studies (14) , this study used it as a self-report questionnaire and therefore the specificity may have been reduced as 30% reported three or more items. However, it is well established that psychotic experiences in adolescence are common (32, 33) . Our conclusions are restricted to adolescent smoking at baseline only, as we are missing the time-dependent data on the continuation of smoking and other confounders. Measures of confounding substance use were limited to single self-report items. We cannot rule out the concurrent use of cannabis with tobacco smoking as an explanation for part or all of the associations reported in this study as cannabis users usually smoke cannabis mixed with tobacco and heavier smoking is also associated with heavier cannabis use (34) and we adjusted only for the binary measure of use. Follow-up for psychosis ended at 30 years. Some individuals will go on to develop psychosis after this age and this may attenuate the association between tobacco smoking and psychosis. Last, we were not able to adjust for potential confounding due to the childhood or familial adversity.
Heavy smoking in adolescence was independently associated with increased risk for subsequent psychosis even after adjustment for baseline psychotic experiences, substance use, and parental history of psychosis and substance abuse. Earlier initiation of daily smoking resulted in a greater risk of psychosis compared to those who began smoking daily later. The data are consistent with the hypothesis that tobacco smoking is an independent risk factor for psychotic disorders. In addition to the many other health problems, the evidence is mounting that use of tobacco in adolescence may contribute to serious mental illness in young adults. This is another reason to implement effective strategies to prevent adolescents from commencing use of tobacco.
